首页> 中文期刊> 《肿瘤药学》 >中药卷柏抗肿瘤作用及新型炔酚类化合物Selaginellin 的研究进展

中药卷柏抗肿瘤作用及新型炔酚类化合物Selaginellin 的研究进展

         

摘要

卷柏属植物资源丰富,药理作用广泛,近年来国内外在卷柏属药用植物的资源、活性成分、药理作用等方面有很多新发现和研究。特别是卷柏属植物的抗肿瘤作用引起了广大学者的关注,目前多认为卷柏属植物中的双黄酮类是其发挥抗肿瘤作用的主要物质。细胞毒作用,诱导细胞凋亡,阻滞肿瘤细胞的侵袭、转移,是双黄酮类发挥抗肿瘤作用的主要机制。卷柏属新型炔酚类化合物 Selaginellin 是近几年分离得到的新型碳骨架化合物,除了具有抗氧化作用外,最近发现其能通过发挥细胞毒作用,从而起到抗肿瘤的作用。本文针对近年来对卷柏属植物的抗肿瘤作用及其机制的研究概况以及对 Selaginellin 的研究历程、抗肿瘤作用等研究概况进行综述。%  Plants in Selaginella Genus are in abundance on the earth, and can be applied in many medical situations. Recently there are a lot of new discoveries and researches being done in exploring the resources, active components, and pharmaceutical effects of Selaginella nationally and internationally. During all these discoveries, the anti-tumor activity of Selaginella attracts more and more scholars, and Bisflavones in Selaginellin are considered the chief effective ingredient. Cytotoxicity, induction of apoptosis, blocking the invasion of tumor cells, transfer are the main mechanisms of pairs of flavonoids which plays anti-tumor effect. Selaginellin isolated in recent years was a new type of carbon skeleton of com-pounds, in addition to its antioxidant activity, recently its cytotoxicity have been found playing the role of anti-tumor. This article provides a general review for the research progress and pharmaceutical effects of Selaginellin, anti-tumor ac-tivity of Selaginella, and its mechanisms in the last few years.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号